CD274 and neoplasm: The efficiency of immunotherapy is influenced by tumor cell intrinsic factors, such as PD-L1 expression (in the case of PD-1/PD-L1 targeting agents), tumor mutation burden (TMB) and neoantigen and HLA expression [165,166], as well as by tumor cell extrinsic factors, derived from the TME.